After a brief news lull around medtech regulatory system changes for the UK, the government and Medicines and Healthcare products Regulatory Agency (MHRA) issued several updates on new structures and access to medtech and healthtech in late May.
Among them was the government’s response to the chief scientific advisor’s (CSA) report on the pro-innovation regulation of emerging life...